Free Trial

Versor Investments LP Buys New Position in Novanta Inc. (NASDAQ:NOVT)

Novanta logo with Computer and Technology background
Remove Ads

Versor Investments LP bought a new stake in Novanta Inc. (NASDAQ:NOVT - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,800 shares of the technology company's stock, valued at approximately $275,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. KBC Group NV grew its position in Novanta by 14.9% during the third quarter. KBC Group NV now owns 1,059 shares of the technology company's stock worth $189,000 after buying an additional 137 shares in the last quarter. Nicolet Advisory Services LLC grew its holdings in shares of Novanta by 5.9% during the third quarter. Nicolet Advisory Services LLC now owns 2,502 shares of the technology company's stock worth $430,000 after purchasing an additional 139 shares in the last quarter. M&T Bank Corp increased its position in shares of Novanta by 4.5% in the third quarter. M&T Bank Corp now owns 3,619 shares of the technology company's stock worth $647,000 after purchasing an additional 155 shares during the last quarter. Empowered Funds LLC purchased a new stake in Novanta in the fourth quarter valued at approximately $26,000. Finally, Van ECK Associates Corp lifted its position in Novanta by 28.4% during the third quarter. Van ECK Associates Corp now owns 963 shares of the technology company's stock valued at $166,000 after purchasing an additional 213 shares during the last quarter. Institutional investors own 98.35% of the company's stock.

Novanta Price Performance

Shares of NOVT traded up $1.02 during midday trading on Friday, reaching $142.99. The stock had a trading volume of 189,280 shares, compared to its average volume of 161,414. The company has a current ratio of 2.79, a quick ratio of 1.81 and a debt-to-equity ratio of 0.61. The company has a market capitalization of $5.14 billion, a price-to-earnings ratio of 85.62 and a beta of 1.34. The company's 50-day moving average is $147.58 and its 200 day moving average is $163.38. Novanta Inc. has a 12-month low of $136.02 and a 12-month high of $187.12.

Remove Ads

Novanta (NASDAQ:NOVT - Get Free Report) last issued its quarterly earnings results on Tuesday, February 25th. The technology company reported $0.76 EPS for the quarter, beating analysts' consensus estimates of $0.71 by $0.05. The business had revenue of $238.10 million for the quarter, compared to analysts' expectations of $240.29 million. Novanta had a net margin of 6.52% and a return on equity of 15.20%. The business's quarterly revenue was up 12.5% on a year-over-year basis. During the same period last year, the business earned $0.63 earnings per share. On average, equities analysts predict that Novanta Inc. will post 3.03 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Robert W. Baird lowered their price objective on shares of Novanta from $169.00 to $160.00 and set a "neutral" rating on the stock in a research report on Monday.

Check Out Our Latest Research Report on NOVT

Novanta Company Profile

(Free Report)

Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.

Further Reading

Institutional Ownership by Quarter for Novanta (NASDAQ:NOVT)

Should You Invest $1,000 in Novanta Right Now?

Before you consider Novanta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novanta wasn't on the list.

While Novanta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Top Nuclear Stocks To Buy Now Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

7 Inflation-Proof Stocks to Protect Your Portfolio

7 Inflation-Proof Stocks to Protect Your Portfolio

Inflation is sticking around—is your portfolio ready? In this video, we break down 7 stocks that could help shield your investments from inflation’s impact.

Recent Videos

Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads